Search Results - "Hoitsma, A."

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry by Spithoven, Edwin M, Kramer, Anneke, Meijer, Esther, Orskov, Bjarne, Wanner, Christoph, Abad, Jose M, Aresté, Nuria, de la Torre, Ramón Alonso, Caskey, Fergus, Couchoud, Cécile, Finne, Patrik, Heaf, James, Hoitsma, Andries, de Meester, Johan, Pascual, Julio, Postorino, Maurizio, Ravani, Pietro, Zurriaga, Oscar, Jager, Kitty J, Gansevoort, Ron T

“…Autosomal dominant polycystic kidney disease (ADPKD) is the fourth most common renal disease requiring renal replacement therapy (RRT). Still, there are few…”
Get full text

The Course and Predictors of Health‐Related Quality of Life in Living Kidney Donors: A Systematic Review and Meta‐Analysis by Wirken, L., van Middendorp, H., Hooghof, C. W., Rovers, M. M., Hoitsma, A. J., Hilbrands, L. B., Evers, A. W. M.

“…A better understanding of the course and risk factors for impaired long‐term health‐related quality of life (HRQoL; ie, physical, psychological, and…”
Get full text

Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry by Vogelzang, Judith L, van Stralen, Karlijn J, Noordzij, Marlies, Diez, Jose Abad, Carrero, Juan J, Couchoud, Cecile, Dekker, Friedo W, Finne, Patrik, Fouque, Denis, Heaf, James G, Hoitsma, Andries, Leivestad, Torbjørn, de Meester, Johan, Metcalfe, Wendy, Palsson, Runolfur, Postorino, Maurizio, Ravani, Pietro, Vanholder, Raymond, Wallner, Manfred, Wanner, Christoph, Groothoff, Jaap W, Jager, Kitty J

“…Infections and malignancies are the most common non-cardiovascular causes of death in patients on chronic renal replacement therapy (RRT). Here, we aimed to…”
Get full text

Reactivation of Latent HPV Infections After Renal Transplantation by Hinten, F., Hilbrands, L. B., Meeuwis, K. A. P., IntHout, J., Quint, W. G. V., Hoitsma, A. J., Massuger, L. F. A. G., Melchers, W. J. G., Hullu, J. A.

“…Female renal transplant recipients (RTRs) have an increased risk for developing human papillomavirus (HPV)–related (pre)malignant lesions of the genital tract…”
Get full text

Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients by OCAK, G., VAN STRALEN, K. J., ROSENDAAL, F. R., VERDUIJN, M., RAVANI, P., PALSSON, R., LEIVESTAD, T., HOITSMA, A. J., FERRER‐ALAMAR, M., FINNE, P., DE MEESTER, J., WANNER, C., DEKKER, F. W., JAGER, K. J.

“…See also Zoccali C, Mallamaci F. Pulmonary embolism in chronic kidney disease: a lethal, overlooked and research orphan disease. This issue, pp 2481–3…”
Get full text

The Natural History of Clinical Operational Tolerance After Kidney Transplantation Through Twenty‐Seven Cases by Brouard, S., Pallier, A., Renaudin, K., Foucher, Y., Danger, R., Devys, A., Cesbron, A., Guillot‐Guegen, C., Ashton‐Chess, J., Le Roux, S., Harb, J., Roussey, G., Subra, J.‐F., Villemain, F., Legendre, C., Bemelman, F.J., Orlando, G., Garnier, A., Jambon, H., Le Monies De Sagazan, H., Braun, L., Noël, C., Pillebout, E., Moal, M.‐C., Cantarell, C., Hoitsma, A., Ranbant, M., Testa, A., Soulillou, J.‐P., Giral, M.

“…We report here on a European cohort of 27 kidney transplant recipients displaying operational tolerance, compared to two cohorts of matched kidney transplant…”
Get full text

Deleterious Influence of Prolonged Warm Ischemia in Living Donor Kidney Transplantation by Hellegering, J, Visser, J, Kloke, H.J, D'Ancona, F.C.H, Hoitsma, A.J, van der Vliet, J.A, Warlé, M.C

“…Abstract Background Recent studies investigating early graft function (EGF) after living donor kidney transplantation (LDKT) identified prolonged warm ischemia…”
Get full text

Increasing Consent and Assent Rate for Organ and Tissue Donation: Communication About Donation–Telephone Advice by Psychologist by Ismail, S.Y., Kums, E., Mahmood, S.K., Hoitsma, A.J., Jansen, N.E.

“…A high percentage of family refusal is found for several outcomes in the Donor Register. Misconceptions and concerns regarding donation impede next of kin from…”
Get full text

Controlled donation after circulatory death in the Netherlands: more organs, more efforts by Leiden, H, Haase-Kromwijk, B, Hoitsma, A, Jansen, N

“…The Netherlands was one of the first countries in Europe to stimulate controlled donation after circulatory death (cDCD) at a national level in addition to…”
Get full text

Shared Decision-Making in Kidney Patients: Involvement in Decisions Regarding the Quality of Deceased Donor Kidneys by van Hoogdalem, L.E., Hoitsma, A., Timman, R., van der Zwart, R., Körnmann, J., van Rijssel, T., Busschbach, J.J.V., Ismail, S.Y.

“…This study examined whether kidney patients want to participate in decisions regarding the minimal acceptable quality of deceased donor kidneys. We also…”
Get full text

Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients by van den Akker, J.M., Wetzels, J.F.M., Hoitsma, A.J.

“…Recent studies have reported a significant increase of proteinuria in kidney transplant recipients who were switched from a calcineurin inhibitor (CI) to…”
Get full text

Cervicovaginal HPV Infection in Female Renal Transplant Recipients: An Observational, Self‐Sampling Based, Cohort Study by Meeuwis, K. A. P., Hilbrands, L. B., IntHout, J., Slangen, B. F. M., Hendriks, I. M. P., Hinten, F., Christiaans, M. H. L., Quint, W. G. V., van de Kerkhof, P. C. M., Massuger, L. F. A. G., Hoitsma, A. J., van Rossum, M. M., Melchers, W. J. G., de Hullu, J. A.

“…Immunosuppressive treatment of organ transplant recipients is associated with an increase in the occurrence of human papillomavirus (HPV) related anogenital…”
Get full text

Poor early graft function impairs long-term outcome in living donor kidney transplantation by Hellegering, J., Visser, J., Kloke, H. J., D’Ancona, F. C. H., Hoitsma, A. J., van der Vliet, J. A., Warlé, M. C.

“…Background Poor early graft function (EGF) after living donor kidney transplantation (LDKT) has been found to decrease rejection-free graft survival rates…”
Get full text

Preservation of kidneys from controlled donors after cardiac death by Wind, J., Snoeijs, M. G. J., van der Vliet, J. A., Winkens, B., Christiaans, M. H. L., Hoitsma, A. J., van Heurn, L. W. E.

“…Background: Donation after cardiac death (DCD) expands the pool of donor kidneys, but is associated with warm ischaemic injury. Two methods are used to…”
Get full text

Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin by de Sévaux, R.G.L, Smit, J.V, de Jong, E.M.G.J, van de Kerkhof, P.C.M, Hoitsma, A.J

“…After renal transplantation, the incidence of premalignant and malignant skin lesions is high. Treatment with acitretin improves the number and aspect of…”
Get full text

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation by Hale, Michael D., Nicholls, Andrew J., Bullingham, Roy E.S., Hené, Ronald, Hoitsma, A., Squifflet, Jean‐Paul, Weimar, W., Vanrenterghem, Yves, Van de Woude, Fokko J., Verpooten, Gert A.

“…Background Mycophenolate mofetil, a pro‐drug for mycophenolic acid, reduces the likelihood of allograft rejection after renal transplantation. We studied the…”
Get full text

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies? by Kamburova, E. G., Wisse, B. W., Joosten, I., Allebes, W. A., van der Meer, A., Hilbrands, L. B., Baas, M. C., Spierings, E., Hack, C. E., van Reekum, F. E., van Zuilen, A. D., Verhaar, M., Bots, M. L., Drop, A. C. A. D., Plaisier, L., Seelen, M. A. J., Sanders, J. S. F., Hepkema, B. G., Lambeck, A. J., Bungener, L. B., Roozendaal, C., Tilanus, M. G. J., Vanderlocht, J., Voorter, C. E., Wieten, L., van Duijnhoven, E. M., Gelens, M., Christiaans, M. H. L., van Ittersum, F. J., Nurmohamed, A., Lardy, N. M., Swelsen, W., van der Pant, K. A., van der Weerd, N. C., ten Berge, I. J. M., Bemelman, F. J., Hoitsma, A., van der Boog, P. J. M., de Fijter, J. W., Betjes, M. G. H., Heidt, S., Roelen, D. L., Claas, F. H., Otten, H. G.

“…Solid‐phase multiplex‐bead assays are widely used in transplantation to detect anti‐human leukocyte antigen (HLA) antibodies. These assays enable high…”
Get full text

Low-pressure pneumoperitoneum during laparoscopic donor nephrectomy to optimize live donors' comfort by Warlé, M.C., Berkers, A.W., Langenhuijsen, J.F, van der Jagt, M.F., Dooper, Ph.M., Kloke, H.J., Pilzecker, D., Renes, S.H., Wever, K.E., Hoitsma, A.J., van der Vliet, J.A., D'Ancona, F.C.H.

“…Nowadays, laparoscopic donor nephrectomy (LDN) has become the gold standard to procure live donor kidneys. As the relationship between donor and recipient…”
Get full text

Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients by GREGOOR, P. J. H. S, DE SEVAUX, R. G. L, HENE, R. J, HESSE, C. J, HILBRANDS, L. B, VOS, P, VAN GELDER, T, HOITSMA, A. J, WEIMAR, W

“…Triple drug treatment consisting of mycophenolate mofetil (MMF), in a standard dose of 2 g daily, combined with cyclosporine (CsA) and prednisone, has become…”
Get full text

Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry by Wühl, Elke, van Stralen, Karlijn J, Wanner, Christoph, Ariceta, Gema, Heaf, James Goya, Bjerre, Anna K, Palsson, Runolfur, Duneau, Gabrielle, Hoitsma, Andries J, Ravani, Pietro, Schaefer, Franz, Jager, Kitty J

“…In recent years, increased efforts have been undertaken to address the needs of patients with rare diseases by international initiatives and consortia devoted…”
Get full text